Can aminotransferase-to-platelet ratio index and other non-invasive markers effectively reduce liver biopsies for renal transplant evaluation of hepatitis C virus-positive patients?

Nephrology Dialysis Transplantation

Volumn 29, Issue 6, 2014, Pages 1247-1252

  Jiang, Yan ^a   Huang, Edmund ^a   Mehrnia, Alireza ^a   Kamgar, Mandana ^a   Pham, Phuong T ^a   Ogunorunyinka, Olaoluwapo ^a   Brown, Isaiah ^a   Danovitch, Gabriel M ^a   Bunnapradist, Suphamai ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hepatitis c; liver fibrosis; non invasive markers; renal transplant

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN; INTERFERON;

ABNORMAL LABORATORY RESULT; ADULT; AMINOTRANSFERASE TO PLATELET RATIO INDEX; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE TRACT PARAMETERS; DISEASE MARKER; FEMALE; HEMATOLOGICAL PARAMETERS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY GRAFT; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; PATIENT INFORMATION; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

HEPATITIS C; LIVER FIBROSIS; NON-INVASIVE MARKERS; RENAL TRANSPLANT;

ADULT; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BIOPSY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PLATELET COUNT; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 84901745221     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gft485     Document Type: Article

References (31)

1. Fabrizi F, Martin P, Ponticelli C. Hepatitis C virus infection and renal transplantation. Am J Kidney Dis 2001; 38: 919-934 (Pubitemid 33022168)
2. Chan TM, Lok AS, Cheng IK. Hepatitis C in renal transplant recipients. Transplantation 1991; 52: 810-813
3. Huang CC, Liaw YF, Lai MK et al. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763-765
4. Periera BJ, Wright TL, Schmid CH et al. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799-805
5. Stempel CA, Lake J, Kuo G et al. Hepatitis C-its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273-276 (Pubitemid 23065453)
6. Knoll GA, Tankersley MR, Lee JY et al. The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997; 29: 608-614 (Pubitemid 27155284)
7. Pereira BJ, Natov SN, Bouthot BA et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374-1381 (Pubitemid 28316901)
8. Roth D, Gaynor JJ, Reddy KR et al. Effect of kidney transplantation on outcomes among patients with hepatitis C. J Am Soc Nephrol 2011; 22: 1152-1160
9. Mathurin P, Mouquet C, Poynard T et al. Impact of hepatitis B and C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-263 (Pubitemid 29024011)
10. KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease. Kidney Int Suppl 2008: S1-S99
11. Martin P, Carter D, Fabrizi F et al. Histopathological features of hepatitis C in renal transplant candidates [see comment]. Transplantation 2000; 69: 1479-1484 (Pubitemid 30238744)
12. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500 (Pubitemid 32164902)
13. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618
14. Ozdogan M, Ozgur O, Boyacioglu S et al. Percutaneous liver biopsy complications in patients with chronic renal failure. Nephron 1996; 74: 442-443 (Pubitemid 26326730)
15. Bourliere M, Penaranda G, Renou C et al. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006; 13: 659-670 (Pubitemid 44401194)
16. Carbone M, Cockwell P, Neuberger J. Hepatitis C and kidney transplantation. Int J Nephrol 2011: 593291
17. Lin ZH, Xin YN, Dong QJ et al. Performance of the aspartate aminotransferase- to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011; 53: 726-736
18. Liu CH, Liang CC, Liu CJ et al. The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. Kidney Int 2010; 78: 103-109
19. Schiavon LL, Schiavon JL, Filho RJ et al. Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology 2007; 46: 307-314 (Pubitemid 47344764)
20. Shaheen AA, Myers RP. Diagnostic accuracy of the aspartate aminotransferase- to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review. Hepatology 2007; 46: 912-921 (Pubitemid 47436137)
21. Snyder N, Gajula L, Xiao SY et al. APRI: an easy and validated predictor of hepatic fibrosis in chronic hepatitis C. J Clin Gastroenterol 2006; 40: 535-542 (Pubitemid 44318139)
22. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526 (Pubitemid 36919874)
23. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10 (Pubitemid 34700756)
24. Tang IY, Walzer N, Aggarwal N et al. Management of the kidney transplant patient with chronic hepatitis C infection. Int J Nephrol 2011: 245823
25. Cotler SJ, Diaz G, Gundlapalli S et al. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002; 35: 191-195 (Pubitemid 34815860)
26. Sterling RK, Sanyal AJ, Luketic VA et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-3582
27. Bonekamp S, Kamel I, Solga S et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009; 50: 17-35
28. Choong CC, Venkatesh SK, Siew EP. Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci 2012; 2: 58
29. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-847
30. Munoz R, Ramirez E, Fernandez I et al. Correlation between fibroscan, liver biopsy, and clinical liver function in patients with hepatitis C virus infection after renal transplantation. Transplant Proc 2009; 41: 2425-2426
31. Liu CH, Liang CC, Huang KW et al. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol 2011; 6: 1057-1065